Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)

ClinicalTrials.gov ID: NCT01500434

Public ClinicalTrials.gov record NCT01500434. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions - Long Lesion Sub-trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and effectiveness of the PROMUS Element™ Everolimus-Eluting Coronary Stent System for the treatment of patients with up to 2 de novo atherosclerotic coronary artery lesions. The lesions can be longer than average-sized.

Study identification

NCT ID
NCT01500434
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boston Scientific Corporation
Industry
Enrollment
102 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2009 (Type not available)
Primary completion
Mar 2011 (Actual)
Completion
May 2015 (Actual)
Last update posted
Mar 26, 2019

2009 – 2015

United States locations

U.S. sites
21
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
Scripps Clinic La Jolla California 92037 —
Mercy General Hospital Sacramento California 95819 —
Alvarado Hospital San Diego California 92120 —
MediQuest Research Group Inc. at Munroe Regional Medical Center Ocala Florida 34471 —
Florida Hospital Orlando Florida 32803 —
Maine Medical Center Portland Maine 04102 —
Northern Michigan Hospital Petoskey Michigan 49770 —
William Beaumont Hospital Royal Oak Michigan 48073 —
Abbott Northwestern Hospital Minneapolis Minnesota 55407 —
North Mississippi Medical Center Tupelo Mississippi 38801 —
Columbia University Medical Center New York New York 10032 —
Moses H. Cone Memorial Hospital/LeBauer Cardiovascular Research Foundation Greensboro North Carolina 27401 —
Wake Medical Center Raleigh North Carolina 27610 —
Ohio State University Medical Center Columbus Ohio 43210 —
Ohio Health Research and Innovation Institute Columbus Ohio 43214 —
Mercy St. Vincent Medical Center Toledo Ohio 43608 —
Oklahoma Foundation for Cardiovascular Research Oklahoma City Oklahoma 73120 —
Providence St. Vincent Medical Center Portland Oregon 97225 —
Jackson-Madison County General Hospital Jackson Tennessee 38301 —
TexSAn Heart Hospital San Antonio Texas 78229 —
Providence Health & Services - Washington Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01500434, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 26, 2019 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01500434 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →